Literature DB >> 20676915

Visual evoked potentials findings in non-affected subjects from a large Brazilian pedigree of 11778 Leber's hereditary optic neuropathy.

Paula Yuri Sacai1, Solange Rios Salomão, Valerio Carelli, Josenilson Martins Pereira, Rubens Belfort, Alfredo Arrigo Sadun, Adriana Berezovsky.   

Abstract

To investigate pattern-reversal visual evoked potentials (PRVEP) in asymptomatic maternally and non-maternally related members from a large Brazilian 11778/ND4 LHON pedigree. Transient PRVEP for check sizes 15' and 60' were recorded from asymptomatic mutation carriers and non-mutant descendants of affected/non-affected males, all with best-corrected visual acuity of 20/20. A control group of spouses (off-pedigree) was also included. Parameters of N75, P100 and N135 latencies (ms) and N75-P100 peak-to-peak amplitude (μV) as well as temporal dispersion (latency of N135-latency of N75) were determined. Longitudinal testing was obtained in a subseries of carriers in three annual consecutive visits. We tested 48 asymptomatic mutation carriers, 19 descendants of affected males, 9 descendants of non-affected males and 27 off-pedigrees, all of the latter being non-mutant. All non-mutant male descendants did not differ from off-pedigree controls. Statistically prolonged P100 latencies were found in mutation carriers (P = 0.0143) when compared with off-pedigrees for check sizes 15', as well as significantly larger temporal dispersions for both check size 15' (P = 0.0012) and check size 60' (P = 0.0271). Serial testing in 15 mutation carriers disclosed prolonged P100 latencies and larger temporal dispersion that did not change over time. Subclinical PRVEP abnormalities were detected in this large group of asymptomatic carriers of the 11778/ND4 LHON mutation from the same family, confirming and extending previous psychophysical and structural findings of a selective involvement of the parvocellular pathway. PRVEP is a useful test to characterize and monitor visual dysfunction in this devastating disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20676915     DOI: 10.1007/s10633-010-9241-2

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  26 in total

1.  The optic nerve head component of the human ERG.

Authors:  E E Sutter; M A Bearse
Journal:  Vision Res       Date:  1999-02       Impact factor: 1.886

2.  Psychophysical analysis of contrast processing segregated into magnocellular and parvocellular systems in asymptomatic carriers of 11778 Leber's hereditary optic neuropathy.

Authors:  M Gualtieri; M Bandeira; R D Hamer; M F Costa; A G F Oliveira; A L A Moura; F Sadun; A M De Negri; A Berezovsky; S R Salomão; V Carelli; A A Sadun; D F Ventura
Journal:  Vis Neurosci       Date:  2008 May-Jun       Impact factor: 3.241

3.  Visual evoked potentials in Leber's hereditary optic neuropathy.

Authors:  L J Dorfman; E Nikoskelainen; A R Rosenthal; R L Sogg
Journal:  Ann Neurol       Date:  1977-06       Impact factor: 10.422

4.  Serial visual evoked potentials in 90 untreated patients with acute optic neuritis.

Authors:  J L Frederiksen; J Petrera
Journal:  Surv Ophthalmol       Date:  1999-10       Impact factor: 6.048

5.  Leber's optic neuropathy: clinical and visual evoked response studies in asymptomatic and symptomatic members of a 4-generation family.

Authors:  I R Livingstone; F L Mastaglia; J W Howe; G E Aherne
Journal:  Br J Ophthalmol       Date:  1980-10       Impact factor: 4.638

Review 6.  A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine.

Authors:  Douglas C Wallace
Journal:  Annu Rev Genet       Date:  2005       Impact factor: 16.830

7.  Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber's hereditary optic neuropathy mutations.

Authors:  Giacomo Savini; Piero Barboni; Maria Lucia Valentino; Pasquale Montagna; Pietro Cortelli; Anna Maria De Negri; Federico Sadun; Stefania Bianchi; Lora Longanesi; Maurizio Zanini; Valerio Carelli
Journal:  Ophthalmology       Date:  2005-01       Impact factor: 12.079

8.  Visual electrophysiologic findings in patients from an extensive Brazilian family with Leber's hereditary optic neuropathy.

Authors:  Solange R Salomão; Adriana Berezovsky; Rafael E Andrade; Rubens Belfort; Valerio Carelli; Alfredo A Sadun
Journal:  Doc Ophthalmol       Date:  2004-03       Impact factor: 2.379

9.  The clinical findings in Leber's hereditary optic neuroretinopathy. Leber's disease.

Authors:  E Nikoskelainen
Journal:  Trans Ophthalmol Soc U K       Date:  1985

10.  A very large Brazilian pedigree with 11778 Leber's hereditary optic neuropathy.

Authors:  Alfredo A Sadun; Valerio Carelli; Solange R Salomao; Adriana Berezovsky; Peter Quiros; Federico Sadun; Anna-Maria DeNegri; Rafael Andrade; Stan Schein; Rubens Belfort
Journal:  Trans Am Ophthalmol Soc       Date:  2002
View more
  11 in total

1.  Charles Bonnet syndrome in Leber's hereditary optic neuropathy.

Authors:  Hana Kolarova; Claudia B Catarino; Claudia Priglinger; Thomas Klopstock
Journal:  J Neurol       Date:  2019-01-28       Impact factor: 4.849

2.  Visual acuity evaluated by pattern-reversal visual-evoked potential is affected by check size/visual angle.

Authors:  Xiping Chen; Qianqian Li; Xiaoqin Liu; Li Yang; Wentao Xia; Luyang Tao
Journal:  Neurosci Bull       Date:  2012-12-07       Impact factor: 5.203

3.  Mathematically modeling the involvement of axons in Leber's hereditary optic neuropathy.

Authors:  Billy X Pan; Fred N Ross-Cisneros; Valerio Carelli; Kelly S Rue; Solange R Salomao; Milton N Moraes-Filho; Milton N Moraes; Adriana Berezovsky; Rubens Belfort; Alfredo A Sadun
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-09       Impact factor: 4.799

4.  Neuron-specific enolase is elevated in asymptomatic carriers of Leber's hereditary optic neuropathy.

Authors:  Kenneth M Yee; Fred N Ross-Cisneros; Jeong Goo Lee; Arlon Bastos Da Rosa; Solange R Salomao; Adriana Berezovsky; Rubens Belfort; Filipe Chicani; Milton Moraes-Filho; Jerry Sebag; Valerio Carelli; Alfredo A Sadun
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-21       Impact factor: 4.799

Review 5.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

6.  Gender-based normative values for pattern-reversal and flash visually evoked potentials under binocular and monocular stimulation in healthy adults.

Authors:  Patrícia de Freitas Dotto; Adriana Berezovsky; Paula Yuri Sacai; Daniel Martins Rocha; Solange Rios Salomão
Journal:  Doc Ophthalmol       Date:  2017-05-30       Impact factor: 2.379

Review 7.  Medical management of hereditary optic neuropathies.

Authors:  Chiara La Morgia; Michele Carbonelli; Piero Barboni; Alfredo Arrigo Sadun; Valerio Carelli
Journal:  Front Neurol       Date:  2014-07-31       Impact factor: 4.003

8.  Genetic and Clinical Analyses of DOA and LHON in 304 Chinese Patients with Suspected Childhood-Onset Hereditary Optic Neuropathy.

Authors:  Yadi Li; Jie Li; Xiaoyun Jia; Xueshan Xiao; Shiqiang Li; Xiangming Guo
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

9.  Clinical characterization and mitochondrial DNA sequence variations in Leber hereditary optic neuropathy.

Authors:  Manoj Kumar; Punit Kaur; Manoj Kumar; Rohit Saxena; Pradeep Sharma; Rima Dada
Journal:  Mol Vis       Date:  2012-11-12       Impact factor: 2.367

10.  Secondary post-geniculate involvement in Leber's hereditary optic neuropathy.

Authors:  Giovanni Rizzo; Kevin R Tozer; Caterina Tonon; David Manners; Claudia Testa; Emil Malucelli; Maria Lucia Valentino; Chiara La Morgia; Piero Barboni; Ruvdeep S Randhawa; Fred N Ross-Cisneros; Alfredo A Sadun; Valerio Carelli; Raffaele Lodi
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.